{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:15:18Z","timestamp":1790270118747,"version":"4.1.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1111\/j.1574-695x.2007.00311.x","type":"journal-article","created":{"date-parts":[[2007,8,22]],"date-time":"2007-08-22T11:05:09Z","timestamp":1187780709000},"page":"229-242","source":"Crossref","is-referenced-by-count":140,"title":["Immune response to leishmania: paradox rather than paradigm"],"prefix":"10.1093","volume":"51","author":[{"given":"Parul","family":"Tripathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB1","unstructured":"Agnello D , Lankford CS , Bream J et al. (2003) Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 23: 147\u00e2\u0080\u0093161."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB2","doi-asserted-by":"crossref","unstructured":"Ajdary S , Alimohammadian MH , Eslami MB , Kemp K & Kharazmi A (2000) Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun 68: 1760\u00e2\u0080\u00931764.","DOI":"10.1128\/IAI.68.4.1760-1764.2000"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB4","doi-asserted-by":"crossref","unstructured":"Alexander J , Satoskar A & Russell D (1999) Leishmania species: models of intracellular parasitism. J Cell Sci 112: 2993\u00e2\u0080\u00933002.","DOI":"10.1242\/jcs.112.18.2993"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB3","doi-asserted-by":"crossref","unstructured":"Alexander J , Carter KC , Al-Fasi N , Satoskar A & Brombacher F (2000) Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis. Eur J Immunol 30: 2935\u00e2\u0080\u00932943.","DOI":"10.1002\/1521-4141(200010)30:10<2935::AID-IMMU2935>3.0.CO;2-Q"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB5","unstructured":"Almeida RP , Rocha P , Jesus AR , Costa J & Carvalho EM (1995) Evaluation of cellular immune responses in patients with different clinical forms of tegumentary leishmaniasis. Allergy J Immunol 14: 11\u00e2\u0080\u009319."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB6","doi-asserted-by":"crossref","unstructured":"Alvar J , Canavate C , Gutierrez-solar B et al. (1997) Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 10: 298\u00e2\u0080\u0093319.","DOI":"10.1128\/CMR.10.2.298"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB7","unstructured":"Anderson CF , Oukka M , Kuchroo VJ & Sacks D (2007) CD4+CD25\u00e2\u0088\u0092Foxp3\u00e2\u0088\u0092 Th1 cells are the source of IL-10\u00e2\u0080\u0093mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204: 285\u00e2\u0080\u0093297."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB8","doi-asserted-by":"crossref","unstructured":"Antonelli LR , Dutra WO , Almeida RP , Bacellar O & Gollob KJ (2004) Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation. Clin Exp Immunol 136: 341\u00e2\u0080\u0093348.","DOI":"10.1111\/j.1365-2249.2004.02426.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB9","unstructured":"Awasthi A , Mathur RK & Saha B (2004) Immune response to Leishmania infection. Indian J Med Res 119: 238\u00e2\u0080\u0093258."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB10","doi-asserted-by":"crossref","unstructured":"Babaloo Z , Kaye PM & Eslami MB (2001) Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines. Trans R Soc Trop Med Hyg 95: 85\u00e2\u0080\u009388.","DOI":"10.1016\/S0035-9203(01)90344-X"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB11","unstructured":"Bacellar O , Barral-Netto M , Badaro R & Carvalho EM (1991) Gamma interferon production by lymphocytes from children infected with L. chagasi. Braz J Med Biol Res 24: 791\u00e2\u0080\u0093795."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB12","doi-asserted-by":"crossref","unstructured":"Bacellar O , Brodskyn C , Guerreiro J et al. (1996) Interleukin-12 restores interferon-\u00ce\u00b3 production and cytotoxic responses in visceral leishmaniasis. J Infect Dis 173: 1515\u00e2\u0080\u00931518.","DOI":"10.1093\/infdis\/173.6.1515"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB13","doi-asserted-by":"crossref","unstructured":"Barral-Netto M , Barral A , Brownell CE et al. (1992) Transforming growth factor-\u00ce\u00b2 in leishmanial infection: a parasite escape mechanism. Science 257: 545\u00e2\u0080\u0093548.","DOI":"10.1126\/science.1636092"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB14","unstructured":"Barral-Netto M , Brodskyn C , Carvalho EM & Barral A (1998) Human_Leishmaniasis\/cytokines.bahia.br. Braz J Med Biol Res 31: 149\u00e2\u0080\u0093155."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB15","doi-asserted-by":"crossref","unstructured":"Belkaid Y (2003) The role of CD4 (+) CD25 (+) regulatory T cells in Leishmania infection. Expert Opin Biol Ther 3: 875\u00e2\u0080\u0093885.","DOI":"10.1517\/14712598.3.6.875"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB16","doi-asserted-by":"crossref","unstructured":"Belkaid Y , Hoffmann KF , Mendez S et al. (2001) The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194: 1497\u00e2\u0080\u00931506.","DOI":"10.1084\/jem.194.10.1497"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB17","doi-asserted-by":"crossref","unstructured":"Belkaid Y , Piccirillo CA , Mendez S , Shevach EM & Sacks DL (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502\u00e2\u0080\u0093507.","DOI":"10.1038\/nature01152"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB18","unstructured":"Ben-Sasson SZ , Le Gros G , Conrad DH , Finkelman FD & Paul WE (1990) IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J Immunol 145: 1127\u00e2\u0080\u00931136."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB21","doi-asserted-by":"crossref","unstructured":"Biedermann T , Zimmermann S , Himmelrich H et al. (2001) IL-4 instructs Th1 responses and resistance to Leishmania major in susceptible BALB\/c mice. Nat Immunol 2: 1054\u00e2\u0080\u00931060.","DOI":"10.1038\/ni725"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/978-3-642-57863-2_14","volume-title":"Tropical Pathology","author":"Bittencourt","year":"1995"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB23","doi-asserted-by":"crossref","unstructured":"Bogdan C , Gessner A & Rollinghoff M (1993) Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 189: 356\u00e2\u0080\u0093396.","DOI":"10.1016\/S0171-2985(11)80366-9"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB24","doi-asserted-by":"crossref","unstructured":"Bogdan C , Gessner A , Solbach W & Rollinghoff M (1996) Invasion, control and persistence of Leishmania parasites. Curr Opin Immunol 8: 517\u00e2\u0080\u0093525.","DOI":"10.1016\/S0952-7915(96)80040-9"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB25","doi-asserted-by":"crossref","unstructured":"Bogdan C , Rollinghof M & Diefenbach A (2000) The role of nitric oxide in innate immunity. Immunol Rev 173: 17\u00e2\u0080\u009326.","DOI":"10.1034\/j.1600-065X.2000.917307.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB26","doi-asserted-by":"crossref","unstructured":"Bottrel RL , Dutra WO , Martins FA et al. (2001) Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 69: 3232\u00e2\u0080\u00933239.","DOI":"10.1128\/IAI.69.5.3232-3239.2001"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB27","doi-asserted-by":"crossref","unstructured":"Bourreau E , Gardon J , Pradinaud R et al. (2003) Th2 responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses. Infect Immun 71: 2244\u00e2\u0080\u00932246.","DOI":"10.1128\/IAI.71.4.2244-2246.2003"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB30","doi-asserted-by":"crossref","unstructured":"Caldas A , Favali C , Aquino D et al. (2005) Balance of IL-10 and interferon-\u00ce\u00b3 plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 5: 113.","DOI":"10.1186\/1471-2334-5-113"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4615-0955-4_12","volume-title":"Leishmania","volume":"4","author":"Campos-Neto","year":"2002"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB31","doi-asserted-by":"crossref","unstructured":"Campos-Neto A (2005) What about Th1\/Th2 in cutaneous leishmaniasis vaccine discovery? Braz J Med Biol Res 38: 979\u00e2\u0080\u0093984.","DOI":"10.1590\/S0100-879X2005000700001"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB33","doi-asserted-by":"crossref","unstructured":"Campos-Neto A , Soong L , Cordova JL et al. (1995) Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J Exp Med 182: 1423\u00e2\u0080\u00931433.","DOI":"10.1084\/jem.182.5.1423"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB32","doi-asserted-by":"crossref","unstructured":"Campos-Neto A , Porrozzi R , Greeson K et al. (2001) Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infect Immun 69: 4103\u00e2\u0080\u00934108.","DOI":"10.1128\/IAI.69.6.4103-4108.2001"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB35","doi-asserted-by":"crossref","unstructured":"Carrera L , Gazzinelli RT , Badolato R et al. (1996) Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 183: 515\u00e2\u0080\u0093526.","DOI":"10.1084\/jem.183.2.515"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB38","doi-asserted-by":"crossref","unstructured":"Carvalho EM , Badar\u00c3\u00b3 R , Reed SG , Jones TC & Johnson WD (1985) Absence of gamma interferon and interleukin-2 production during active visceral leishmaniasis. J Clin Invest 76: 2066\u00e2\u0080\u00932069.","DOI":"10.1172\/JCI112209"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB36","doi-asserted-by":"crossref","unstructured":"Carvalho EM , Bacellar O , Barral A , Badaro R & Johnson WD Jr (1989) Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 83: 860\u00e2\u0080\u0093864.","DOI":"10.1172\/JCI113969"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB39","doi-asserted-by":"crossref","unstructured":"Carvalho EM , Barral A , Pedral-Sampaio D et al. (1992) Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J Infect Dis 165: 535\u00e2\u0080\u0093540.","DOI":"10.1093\/infdis\/165.3.535"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB37","doi-asserted-by":"crossref","unstructured":"Carvalho EM , Bacellar O , Brownell C , R\u00c3\u00a9gis T , Coffman RL & Reed SG (1994) Restoration of IFN-\u00ce\u00b3 production and lymphocyte proliferation in visceral leishmaniasis. J Immunol 152: 5949\u00e2\u0080\u00935956.","DOI":"10.4049\/jimmunol.152.12.5949"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB40","doi-asserted-by":"crossref","unstructured":"Chatelain R , Mauze S & Coffman RL (1999) Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 21: 211\u00e2\u0080\u0093218.","DOI":"10.1046\/j.1365-3024.1999.00224.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB41","doi-asserted-by":"crossref","unstructured":"Cillari E , Vitale G , Arcoleo F et al. (1995) In vivo and in vitro cytokine profiles and mononuclear cell subsets in Sicilian patients with active visceral leishmaniasis. Cytokine 7: 740\u00e2\u0080\u0093745.","DOI":"10.1006\/cyto.1995.0088"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB42","doi-asserted-by":"crossref","unstructured":"Costa SR , D'Oliveira A Jr , Bacellar O & Carvalho EM (1999) T cell response of asymptomatic Leishmania chagasi infected subjects to recombinant leishmania antigens. Mem Inst Oswaldo Cruz 94: 367\u00e2\u0080\u0093370.","DOI":"10.1590\/S0074-02761999000300015"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB43","doi-asserted-by":"crossref","unstructured":"D'Oliveira A Jr , Costa SR , Barbosa AB , Orge M de la G & Carvalho EM (1997) Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis. Mem Inst Oswaldo Cruz 92: 15\u00e2\u0080\u009320.","DOI":"10.1590\/S0074-02761997000100003"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB45","unstructured":"Follador I , Araujo C , Bacellar O et al. (2002) Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection. Clin Infect Dis 34: E54\u00e2\u0080\u0093E58."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB46","doi-asserted-by":"crossref","unstructured":"Gaafar A , Kharazmi A , Ismail A et al. (1995) Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections. Clin Exp Immunol 100: 239\u00e2\u0080\u0093245.","DOI":"10.1111\/j.1365-2249.1995.tb03660.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB47","doi-asserted-by":"crossref","unstructured":"Gantt KR , Schultz-Cherry S , Rodriguez N et al. (2003) Activation of TGF-\u00ce\u00b2 by Leishmania chagasi: importance for parasite survival in macrophages. J Immunol 170: 2613\u00e2\u0080\u00932620.","DOI":"10.4049\/jimmunol.170.5.2613"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB111","unstructured":"Garg R & Dube A (2006) Animal models for vaccine studies for visceral Leishmaniasis. Int J Med Res 123: 439\u00e2\u0080\u0093454."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB48","doi-asserted-by":"crossref","unstructured":"Ghalib HW , Piuvezam MR , Skeiky YA et al. (1993) Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest 92: 324\u00e2\u0080\u0093329.","DOI":"10.1172\/JCI116570"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB49","doi-asserted-by":"crossref","unstructured":"Ghalib HW , Whittle JA , Kubin M et al. (1995) IL-12 enhances Th1-type responses in human Leishmania donovani infections. J Immunol 154: 4623\u00e2\u0080\u00934629.","DOI":"10.4049\/jimmunol.154.9.4623"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB51","unstructured":"Gorak PM , Engwerda CR & Kaye PM (1998) Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 28: 687\u00e2\u0080\u0093695."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB52","doi-asserted-by":"crossref","unstructured":"Hailu A , van Baarle D , Knol GJ , Berhe N , Miedema F & Kager PA (2005) T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani. Clin Immunol 117: 182\u00e2\u0080\u0093191.","DOI":"10.1016\/j.clim.2005.06.015"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB53","doi-asserted-by":"crossref","unstructured":"Haldar JP , Ghose S , Saha KC & Ghose AC (1983) Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun 42: 702\u00e2\u0080\u0093707.","DOI":"10.1128\/IAI.42.2.702-707.1983"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB55","doi-asserted-by":"crossref","unstructured":"Handman E (2001) Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 14: 229\u00e2\u0080\u0093243.","DOI":"10.1128\/CMR.14.2.229-243.2001"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB56","doi-asserted-by":"crossref","unstructured":"Heinzel FP , Rerko RM , Hatam F & Locksley RM (1993a) IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J Immunol 150: 3924\u00e2\u0080\u00933931.","DOI":"10.4049\/jimmunol.150.9.3924"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB57","doi-asserted-by":"crossref","unstructured":"Heinzel FP , Schoenhaut DS , Rerko RM , Rosser LE & Gately MK (1993b) Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177: 1505\u00e2\u0080\u00931509.","DOI":"10.1084\/jem.177.5.1505"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB58","doi-asserted-by":"crossref","unstructured":"Jones DE , Merle Elloso M & Scott P (1998) Host susceptibility factors to cutaneous leishmaniasis. Front Bios 3: d1171\u00e2\u0080\u0093d1180.","DOI":"10.2741\/A353"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB60","doi-asserted-by":"crossref","unstructured":"Julia V , Rassoulzadegan M & Glaichenhaus N (1996) Resistance to Leishmania major induced by tolerance to a single antigen. Science 274: 421\u00e2\u0080\u0093423.","DOI":"10.1126\/science.274.5286.421"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB112","unstructured":"Karp CL , El-Safi SH , Wynn TA et al. (1993) In vivo cytokine profiles in patients with kalaazar. Marked elevation of both interleukin-10 and interferon-\u00ce\u00b3. J Clin Invest 91: 1265\u00e2\u0080\u00931266."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB61","doi-asserted-by":"crossref","unstructured":"Kemp K , Kemp M , Kharazmi A et al. (1999) Leishmania-specific T cells expressing interferon-gamma (IFN-\u00ce\u00b3) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin Exp Immunol 16: 500\u00e2\u0080\u0093504.","DOI":"10.1046\/j.1365-2249.1999.00918.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB62","doi-asserted-by":"crossref","unstructured":"Khalil EA , Ayed NB , Musa AM et al. (2005) Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clin Exp Immunol 140: 349\u00e2\u0080\u0093353.","DOI":"10.1111\/j.1365-2249.2005.02768.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB63","unstructured":"Kolde G , Luger T , Sorg C & Sunderk\u00c3\u00b6tter C (1996) Successful treatment of cutaneous leishmaniasis using interferon-\u00ce\u00b3. Dermatology 192: 56\u00e2\u0080\u009360."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB64","unstructured":"Konecny P , Stagg AJ , Jebbari H , English N , Davidson RN & Knight SC (1999) Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12p40 and stimulate primary T cell proliferation in vitro. Eur J Immunol 29: 1803\u00e2\u0080\u00931811."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB65","doi-asserted-by":"crossref","unstructured":"Kopf M , Brombacher F , Kohler G et al. (1996) IL-4-deficient BALB\/c mice resist infection with Leishmania major. J Exp Med 184: 1127\u00e2\u0080\u00931136.","DOI":"10.1084\/jem.184.3.1127"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB67","first-page":"1","volume-title":"The Leishmaniasis in Biology and Medicine","author":"Lainson","year":"1987"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB69","unstructured":"Louzir H , Melby PC , Ben Salah A et al. (1998) Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major. J Infect Dis 177: 1687\u00e2\u0080\u00931695."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB70","doi-asserted-by":"crossref","unstructured":"Marovich MA , McDowell MA , Thomas EK & Nutman TB (2000) IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40\/CD40 ligand-dependent process. J Immunol 164: 5858\u00e2\u0080\u00935865.","DOI":"10.4049\/jimmunol.164.11.5858"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB71","doi-asserted-by":"crossref","unstructured":"Martins GA , Hutchins AS & Reiner SL (2005) Transcriptional activators of helper T cell fate are required for establishment but not maintenance of signature cytokine expression. J Immunol 175: 5981\u00e2\u0080\u00935995.","DOI":"10.4049\/jimmunol.175.9.5981"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB72","doi-asserted-by":"crossref","unstructured":"Mattner F , Magram J , Ferrante J et al. (1996) Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 26: 1553\u00e2\u0080\u00931559.","DOI":"10.1002\/eji.1830260722"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB73","doi-asserted-by":"crossref","unstructured":"McMahon-Pratt D & Alexander J (2004) Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol Rev 201: 206\u00e2\u0080\u0093224.","DOI":"10.1111\/j.0105-2896.2004.00190.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB74","doi-asserted-by":"crossref","unstructured":"Melby PC (2002) Recent developments in leishmaniasis. Curr Opin Infect Dis 15: 485\u00e2\u0080\u0093490.","DOI":"10.1097\/00001432-200210000-00005"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB75","doi-asserted-by":"crossref","unstructured":"Miralles GD , Stoeckle MY , McDermott DF , Finkelman FD & Murray HW (1994) Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 62: 1058\u00e2\u0080\u00931063.","DOI":"10.1128\/IAI.62.3.1058-1063.1994"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB76","unstructured":"Mougneau E , Altare F , Wakil AE et al. (1995) Glaichenhaus: expression cloning of a protective Leishmania antigen. Science 268: 563\u00e2\u0080\u0093566."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB78","doi-asserted-by":"crossref","unstructured":"Noben-Trauth N , Kropf P & Muller I (1996) Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271: 987\u00e2\u0080\u0093990.","DOI":"10.1126\/science.271.5251.987"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB79","doi-asserted-by":"crossref","unstructured":"Noben-Trauth N , Lira R , Nagase H , Paul WE & Sacks DL (2003) The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J Immunol 170: 5152\u00e2\u0080\u00935158.","DOI":"10.4049\/jimmunol.170.10.5152"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB80","doi-asserted-by":"crossref","unstructured":"Padigel UM , Alexander J & Farrell JP (2003) The role of interleukin-10 in susceptibility of BALB\/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J Immunol 171: 3705\u00e2\u0080\u00933710.","DOI":"10.4049\/jimmunol.171.7.3705"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB82","unstructured":"Pollock KG , McNeil KS , Mottram JC et al. (2003) The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J Immunol 170: 1746\u00e2\u0080\u00931753."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB83","doi-asserted-by":"crossref","unstructured":"Quinones M , Ahuja SK , Melby PC , Pate L , Reddick RL & Ahuja SS (2000) Preformed membrane associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J Exp Med 192: 507\u00e2\u0080\u0093516.","DOI":"10.1084\/jem.192.4.507"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB85","unstructured":"Reed SG & Scott P (1993) T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol 5: 524\u00e2\u0080\u0093531."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB86","unstructured":"Reed SG , Brownell CE , Russo DM , Silva JS , Grabstein KH & Morrissey PJ (1994) IL-10 mediates susceptibility to Trypanosomacruzi infection. J Immunol 153: 3135\u00e2\u0080\u00933140."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB113","doi-asserted-by":"crossref","unstructured":"Reed SG , Coler RN & Campos-Neto A (2003) Development of a leishmaniasis vaccine: the importance of Mpl. Expert Review of Vaccines 2: 239\u00e2\u0080\u0093252.","DOI":"10.1586\/14760584.2.2.239"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB87","unstructured":"Reiner SL & Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13: 151\u00e2\u0080\u0093177."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB88","doi-asserted-by":"crossref","unstructured":"Ribeiro-de-Jesus A , Almeida RP , Lessa H , Bacellar O & Carvalho EM (1998) Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 31: 143\u00e2\u0080\u0093148.","DOI":"10.1590\/S0100-879X1998000100020"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB89","doi-asserted-by":"crossref","unstructured":"Rogers KA , DeKrey GK , Mbow ML , Gillespie RD , Brodskyn CI & Titus RG (2002) Type 1 and type 2 responses to Leishmania major. FEMS Microbiol Lett 209: 1\u00e2\u0080\u00937.","DOI":"10.1111\/j.1574-6968.2002.tb11101.x"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB90","unstructured":"Sacks D & Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845\u00e2\u0080\u0093858."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB91","unstructured":"Saha S , Mondal S , Banerjee A , Ghose J , Bhowmick S & Ali N (2006) Immune responses in kala-azar. Indian J Med Res 123: 245\u00e2\u0080\u0093266."},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB92","doi-asserted-by":"crossref","unstructured":"Scott P (1998) Differentiation, regulation, and death of T helper cell subsets during infection with Leishmania major. Immunol Res 17: 229\u00e2\u0080\u0093238.","DOI":"10.1007\/BF02786447"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB93","doi-asserted-by":"crossref","unstructured":"Scott P (2003) Development and regulation of cell-mediated immunity in experimental leishmaniasis. Immunol Res 27: 489\u00e2\u0080\u0093498.","DOI":"10.1385\/IR:27:2-3:489"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB94","doi-asserted-by":"crossref","unstructured":"Scott P , Caspar P & Sher A (1990) Protection against Leishmania major in BALB\/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J Immunol 144: 1075\u00e2\u0080\u00931079.","DOI":"10.4049\/jimmunol.144.3.1075"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB114","doi-asserted-by":"crossref","unstructured":"Skeiky YA , Coler RN , Brannon M et al. (2002) Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in Mpl adjuvant. Vaccine 20: 3292\u00e2\u0080\u00933303.","DOI":"10.1016\/S0264-410X(02)00302-X"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB95","doi-asserted-by":"crossref","unstructured":"Snijders A , Kalinski P , Hilkens CM & Kapsenberg ML (1998) High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 10: 1593\u00e2\u0080\u00931598.","DOI":"10.1093\/intimm\/10.11.1593"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB97","doi-asserted-by":"crossref","unstructured":"Suffia I , Reckling SK , Salay G & Belkaid Y (2005) A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol 174: 5444\u00e2\u0080\u00935455.","DOI":"10.4049\/jimmunol.174.9.5444"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB98","doi-asserted-by":"crossref","unstructured":"Suffia IJ , Reckling SK , Piccirillo CA , Goldszmid RS & Belkaid Y (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203: 777\u00e2\u0080\u0093788.","DOI":"10.1084\/jem.20052056"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB100","doi-asserted-by":"crossref","unstructured":"Sypek JP , Chung CL , Mayor SE et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177: 1797\u00e2\u0080\u00931802.","DOI":"10.1084\/jem.177.6.1797"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB101","doi-asserted-by":"crossref","unstructured":"Trinchieri G (2001) Regulatory role of T cells producing both interferon-\u00ce\u00b3 and interleukin-10 in persistent infection. J Exp Med 194: F53\u00e2\u0080\u0093F57.","DOI":"10.1084\/jem.194.10.f53"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB102","doi-asserted-by":"crossref","unstructured":"Trinchieri G (2007) Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 204: 239\u00e2\u0080\u0093243.","DOI":"10.1084\/jem.20070104"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB103","doi-asserted-by":"crossref","unstructured":"Uzonna JE , Spath GF , Beverley SM & Scott P (2004) Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response. J Immunol 172: 3793\u00e2\u0080\u00933797.","DOI":"10.4049\/jimmunol.172.6.3793"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB105","doi-asserted-by":"crossref","unstructured":"von Stebut E & Udey MC (2004) Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect 6: 1102\u00e2\u0080\u00931109.","DOI":"10.1016\/j.micinf.2004.05.024"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB104","doi-asserted-by":"crossref","unstructured":"von Stebut E , Belkaid Y , Jakob T , Sacks DL & Udey MC (1998) Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 188: 1547\u00e2\u0080\u00931552.","DOI":"10.1084\/jem.188.8.1547"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB115","doi-asserted-by":"crossref","unstructured":"Wang ZE , Reiner SL , Zheng S , Dalton DK & Locksley RM (1994) CD4+ effector cells default to the Th2 pathway in interferon-\u00ce\u00b3 deficient mice infected with Leishmania major. J Exp Med 179: 1367\u00e2\u0080\u00931371.","DOI":"10.1084\/jem.179.4.1367"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB116","doi-asserted-by":"crossref","unstructured":"Webb JR , Kaufmann D , Campos-Neto A & Reed SG (1996) Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J Immunol 157: 5034\u00e2\u0080\u00935041.","DOI":"10.4049\/jimmunol.157.11.5034"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB117","unstructured":"WHO (1998) WHO information, by topic or disease. http:\/\/www.who.int\/inf-fs\/en\/fact116.htm\/"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB106","doi-asserted-by":"crossref","unstructured":"Wilhelm P , Ritter U , Labbow S , Donhauser N , Rollinghof M , Bogdan C & Korner H (2001) Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking TNF. J Immunol 166: 4012\u00e2\u0080\u00934019.","DOI":"10.4049\/jimmunol.166.6.4012"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB107","doi-asserted-by":"crossref","unstructured":"Wilson ME , Jeronimo SM & Pearson RD (2005) Immunopathogenesis of infection with the visceralizing Leishmania species. Microb Pathog 38: 147\u00e2\u0080\u0093160.","DOI":"10.1016\/j.micpath.2004.11.002"},{"key":"10.1111\/j.1574-695X.2007.00311.x-BIB109","doi-asserted-by":"crossref","unstructured":"Xu D , Liu H , Komai-Koma M et al. (2003) CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol 170: 394\u00e2\u0080\u0093399.","DOI":"10.4049\/jimmunol.170.1.394"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/51\/2\/229\/19422640\/51-2-229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T14:09:42Z","timestamp":1708178982000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1111\/j.1574-695X.2007.00311.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-695x.2007.00311.x","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}